JAZZ
Jazz Pharmaceuticals Plc
NASDAQ · Healthcare · Biotechnology · IE
$208.43
−0.86%Forward multiples
Based on analyst estimates
- P/E forward
- 8.09x
- P/E 2026E
- 8.43x
- P/E 2027E
- 7.97x
- P/E 2028E
- 7.15x
- P/S forward
- 2.74x
Trailing multiples
Trailing twelve months
- P/E TTM
- 13.71x
- PEG TTM
- 0.20x
- Price / book
- 2.82x
- Price / sales
- 2.94x
- Price / cash flow
- 8.15x
Enterprise value
- Enterprise value
- $15.7B
- EV / sales
- 3.42x
- EV / EBITDA
- 9.60x
- EV / EBIT
- 11.02x
- Market cap
- $13.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026